Antrogen ranked among the top searched stocks for 3 days in the past month.

As of 9:30 AM on the 27th, Antrogen is trading at 61,300 KRW, down 0.33% from the previous day. This represents an 81.9% increase compared to May 19. Antrogen is known as a developer and seller of stem cell therapies.

Over the past 5 days, individual investors have net purchased 16,608 shares, while foreign investors and institutions have net sold 4,252 shares and 11,703 shares, respectively.

On May 21, Antrogen became a market issue with the headline "Diabetic Foot Ulcer Treatment Receives FDA Approval, Surges for Second Day."

※Source: AI Investment Assistant AI Rasero

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing